These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14738417)

  • 1. Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication.
    Debus OM; Kurlemann G;
    Epilepsia; 2004 Feb; 45(2):103-8. PubMed ID: 14738417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on treatment with pyridoxine and sulthiame in 12 infants with West syndrome: an open clinical study.
    Debus OM; Köhring J; Fiedler B; Franssen M; Kurlemann G
    Seizure; 2002 Sep; 11(6):381-3. PubMed ID: 12160666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulthiame add-on therapy for epilepsy.
    Milburn-McNulty P; Powell G; Sills GJ; Marson AG
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009472. PubMed ID: 23543577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms.
    Appleton RE; Peters AC; Mumford JP; Shaw DE
    Epilepsia; 1999 Nov; 40(11):1627-33. PubMed ID: 10565592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group.
    Rating D; Wolf C; Bast T
    Epilepsia; 2000 Oct; 41(10):1284-8. PubMed ID: 11051123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of sulthiame on EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS).
    Bast T; Völp A; Wolf C; Rating D;
    Epilepsia; 2003 Feb; 44(2):215-20. PubMed ID: 12558577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
    Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
    Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with vigabatrin and topiramate in West syndrome.
    Buoni S; Zannolli R; Strambi M; Fois A
    J Child Neurol; 2004 May; 19(5):385-6. PubMed ID: 15224711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin as a first-choice drug in the treatment of West syndrome.
    Fejerman N; Cersósimo R; Caraballo R; Grippo J; Corral S; Martino RH; Martino G; Aldao M; Caccia P; Retamero M; Macat MC; Di Blasi MA; Adi J
    J Child Neurol; 2000 Mar; 15(3):161-5. PubMed ID: 10757471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, Single-Blind, Parallel Clinical Trial on Efficacy of Oral Prednisolone Versus Intramuscular Corticotropin on Immediate and Continued Spasm Control in West Syndrome.
    Wanigasinghe J; Arambepola C; Sri Ranganathan S; Sumanasena S; Attanapola G
    Pediatr Neurol; 2015 Sep; 53(3):193-9. PubMed ID: 26216500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic trial of vigabatrin in refractory infantile spasms.
    Chiron C; Dulac O; Beaumont D; Palacios L; Pajot N; Mumford J
    J Child Neurol; 1991; Suppl 2():S52-9. PubMed ID: 1940125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.
    Vigevano F; Cilio MR
    Epilepsia; 1997 Dec; 38(12):1270-4. PubMed ID: 9578521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
    Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
    Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of vigabatrin in west syndrome associated with tuberous sclerosis].
    Ando N; Fujimoto S; Ishikawa T; Kobayashi S; Hattori A; Ito T; Togari H
    No To Hattatsu; 2010 Nov; 42(6):444-8. PubMed ID: 21077355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of pyridoxine to prednisolone in the treatment of infantile spasms: A pilot, randomized controlled trial.
    Kunnanayaka V; Jain P; Sharma S; Seth A; Aneja S
    Neurol India; 2018; 66(2):385-390. PubMed ID: 29547159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of flunarizine as add-on therapy and effect on cognitive outcome in children with infantile spasms.
    Bitton JY; Sauerwein HC; Weiss SK; Donner EJ; Whiting S; Dooley JM; Snead C; Farrell K; Wirrell EC; Mohamed IS; Ronen GM; Salas-Prato M; Amre D; Lassonde M; Carmant L
    Epilepsia; 2012 Sep; 53(9):1570-6. PubMed ID: 22889307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study).
    Borggraefe I; Bonfert M; Bast T; Neubauer BA; Schotten KJ; Maßmann K; Noachtar S; Tuxhorn I; May TW; Heinen F;
    Eur J Paediatr Neurol; 2013 Sep; 17(5):507-14. PubMed ID: 23642492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of West syndrome in Japan.
    Watanabe K
    J Child Neurol; 1995 Mar; 10(2):143-7. PubMed ID: 7782606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.